Recent Company News

• 04:24 PM ET Apr 29, 2026
  

  Autolus Therapeutics announces initiative including reduction in force affecting ~13% of its workforce ($1.41, 0.00)

• 10:50 AM ET Apr 22, 2026
  

  BioMedNewsBreaks -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Leads Shift Toward Pipeline-Driven Valuation in Biotech Sector

• 10:07 AM ET Apr 22, 2026
  

  Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

• 11:17 AM ET Apr 13, 2026
  

  Transcript Intelligence: Autolus Therapeutics at Needham Virtual Healthcare Conference ($1.50, +0.01)

• 06:02 AM ET Apr 13, 2026
  

  Autolus Therapeutics files $150M mixed shelf - S-3 ($1.49, 0.00)

• 04:20 PM ET Apr 08, 2026
  

  Autolus Therapeutics publishes presentation for today's Investor Meeting - 8-K ($1.49, 0.00)

• 02:23 PM ET Apr 08, 2026
  

  Transcript Intelligence: Autolus Therapeutics Investor Meeting ($1.49, +0.13)

• 08:17 AM ET Apr 07, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:20 PM ET Apr 07, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market